课题基金 / 基金详情

COBRE: Eukaryotic Pathogens Innovation Center (EPIC)

COBRE: Eukaryotic Pathogens Innovation Center (EPIC)
COBRE:真核病原体创新中心(EPIC)
批准号:
10666653
负责人:
JAMES Culvin MORRIS
金额:
$221.43万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-15 至 2027-05-31
关键词:
Advisory CommitteesAfrican TrypanosomiasisAmebic colitisAntifungal AgentsAntiparasitic AgentsAreaAspergillosisAspergillus fumigatusAssistantshipAwardAzolesBioinformaticsBiologyBioterrorismCardiovascular DiseasesCell SeparationCenters of Research ExcellenceChagas DiseaseClassificationCollaborationsColon CarcinomaCommunicable DiseasesCommunicationComplexCountryCryptococcusDetectionDevelopmentDiagnosisDiseaseDynein ATPaseDysenteryEducational workshopEnvironmentEnvironmental Risk FactorEquipmentEvolutionFacultyFaculty RecruitmentFosteringFundingFungal MeningitisGenomicsGlobal ChangeGoalsGrantHelminthsHost DefenseHumanImageIncidenceInfectionInfrastructureInstitutionInterdisciplinary StudyKnowledgeLeadershipLightMacrophageMalariaMedicalMeningitisMentorsModelingMusculoskeletal DiseasesOxidantsParasitesParasitic DiseasesPhasePilot ProjectsPostdoctoral FellowPovertyProbabilityProgram Research Project GrantsRegulationResearchResearch PersonnelResource AllocationRoleScientistSouth CarolinaStressStrokeStudent recruitmentToxoplasmosisTrainingTrichomonas InfectionsTrypanosomaUnited States National Institutes of HealthUniversitiesVaccinesVirulenceZebrafishbaseclimate changecollegedietary supplementsdrug discoveryemerging pathogengraduate studenthuman diseaseimaging facilitiesinnovationinsightlipidomicsmembermultidisciplinaryneglectneglected tropical diseasespathogenprimary amebic meningoencephalitisprogramsrecruitresponseskillssuccesstargeted treatmenttenure tracktissue regenerationtransmission processvector

项目摘要

项目成果

JAMES Culvin MORRIS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT Eukaryotic pathogens are the causative agents of some of the most devastating and intractable diseases of humans, including malaria, amebic dysentery, African sleeping sickness, Chagas disease, trichomoniasis, aspergillosis, cryptococcal fungal meningitis, toxoplasmosis and primary amebic meningoencephalitis (PAM). The global impact of these diseases is immense. It is noteworthy that many of these pathogens are the causative agents of neglected tropical diseases (NTDs), neglected diseases of poverty (NDPs) and/or are classified as bioterrorism agents. Importantly, infections caused by eukaryotic pathogens are increasing in the US due to globalization. The primary goal of this COBRE proposal is to increase the number of NIH-funded scientists in the state of South Carolina by supporting a world-class research center, the Eukaryotic Pathogens Innovation Center (EPIC), at Clemson University (CU). The scientific focus of EPIC is a multidisciplinary study of important global eukaryotic pathogens. EPIC is the first-and-only in the state with a focus on infectious diseases, and the first- and-only in the country with a focus on eukaryotic pathogens. Four projects from target junior investigators will be supported. Their projects are 1) Regulation mechanisms of Trypanosome brucei axonemal dynein, 2) Functional roles of ncRNA, afu-182, in azole response and pathobiology of Aspergillus fumigatus, 3) Investigating the function of macrophages in the efficacy of anti-fungal drugs in larval zebrafish, and 4) Evaluating anti-parasitic diazacyclobutenes. These investigators will be matched with external and internal mentors who are established NIH-funded researchers. The projects will be supported by a well-organized Administrative Core and two state-of-the-art Scientific Cores in Genomics, and Imaging/Cell Sorting. The center also has a substantial infrastructure base and significant institutional support. For example, CU will recruit two additional faculty members and two post-doctoral fellows to expand activities of this center over the course of the project period. Pledges of graduate assistantships, equipment, and space further exemplify the institutional commitment. The continuation of this COBRE-funded center will significantly expand research in South Carolina and will facilitate recruitment, training, and retention of a critical mass of investigators with cross-disciplinary skills in this important research area.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enolase inhibitors as therapeutic leads for Naegleria fowleri infections
  • 批准号:
    10739388
  • 项目类别:
  • 资助金额:
    $20.54万
  • 财政年份:
    2023
  • 负责人:
    JAMES Culvin MORRIS
  • 依托单位:
Approaches for genetic manipulation of Naegleria fowleri
  • 批准号:
    10641130
  • 项目类别:
  • 资助金额:
    $19.06万
  • 财政年份:
    2023
  • 负责人:
    JAMES Culvin MORRIS
  • 依托单位:
COBRE: Eukaryotic Pathogens Innovation Center (EPIC)
  • 批准号:
    10494462
  • 项目类别:
  • 资助金额:
    $220.95万
  • 财政年份:
    2022
  • 负责人:
    JAMES Culvin MORRIS
  • 依托单位:
Acquisition of the Agilent Cytation C10 confocal imaging reader for enhancing biomedical research excellence at Clemson University
  • 批准号:
    10798537
  • 项目类别:
  • 资助金额:
    $29.61万
  • 财政年份:
    2022
  • 负责人:
    JAMES Culvin MORRIS
  • 依托单位:
海外基金